Tag: Sun Pharma

Sun

Sun Pharma’s Q1FY26 results

0
In the quarter ended June 2025 (Q1FY26), Sun Pharma's stock's consolidated net profit fell 20% to ₹2,279 crore, dented by a one-time exceptional charge....
tariffs

US exempts Indian pharmaceuticals from reciprocal tariffs

0
In the recent progression of imposing tariffs, U.S. President Donald Trump has exempted Indian pharmaceutical products from the newly imposed reciprocal tariffs. This exemption...
Sun

Sun Pharma to acquire Checkpoint Therapeutics for US$ 355 million 

0
Drug maker Sun Pharma, which is listed on the stock exchange, will acquire Nasdaq-listed Checkpoint Therapeutics, a immunotherapy and targeted oncology company, for $355...
Sun Pharma and Israel-based Moebius Medical have announced that the US Food and Drug Administration (FDA) has granted fast-frack designation (FTD) to MM-II (large liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain.

FDA go-ahead to Sun Pharma to develop osteoarthritis knee pain drug

0
Sun Pharma and Israel-based Moebius Medical have announced that the US Food and Drug Administration (FDA) has granted fast-frack designation (FTD) to MM-II (large...
sun

Sun Pharma to acquire Concert Pharmaceuticals of US

0
Indian multinational pharmaceutical company Sun Pharmaceutical industries will acquire the US-based Concert Pharmaceuticals for $576 million, the company announced on 19 January 2023. Sun Pharma...
Form 483 issued by the USFDA to Sun Pharma

The Halol unit of Sun Pharma receives 10 observations

0
Sun Pharmaceutical Industries said that the health regulator of the US issued a Form 483 having 10 observations after the completion of the inspection...
Sun Pharma has taken over its Galderma's companies, and its share has reached from 1.84% to 871.25 on BSE

Sun Pharma’s subsidiary takes over Galderma’s companies

0
Sun Pharma’s share reaches 1.84% to 871.25 on BSE. About US$99.3 million were paid by Taro after considering working capital adjustments. Sun Pharma captured...
US FDA

US FDA resumes inspections in India

0
In February 2022, FDA officials stated that the agency is eager to resume inspections, including surprise inspections in India. On Thursday, 10 March 2022,...
Molnupiravir

Molnupiravir newest antiviral for Covid-19

0
Molnupiravir, the newest antiviral on the market to treat Covid-19, had been submitted to the Indian drug regulatory authorities for approval. Thirteen were given...
Perfect Containers Group

The modernization of the Perfect Containers Group

0
Founded almost 40 years ago, the Perfect Containers Group is a family-owned and managed business, headquartered in Mumbai with seven manufacturing plants for tubes...

This function has been disabled for HealthTekPak.

error: Content is protected !!